Related Experiment Video
Updated: Aug 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients
Yasunori Hashiguchi1, Hiroshi Tsuda, Takeshi Inoue
1Department of Obstetrics and Gynecology, Osaka City General Hospital, Japan.
Abstract:
The p16-cyclinD1/CDK4-pRb pathway (RB pathway) and p14ARF-MDM2-p53 pathway (p53 pathway) work at the G1-S checkpoint, and the ATM-chk2-CDC25-cyclinB1/cdk1 pathway works at the G2-M checkpoint. The disruption of these pathways is thought to be related to the prognosis of human cancer. In this study, we analyzed the status of these pathways in 107 epithelial ovarian cancer (EOC) patients by immunohistochemistry and evaluated the relationship of these results with chemotherapy response and the prognosis. Altered RB, p53, and G2 pathways were detected in 50.5% (54/107), 51.4% (55/107), and 33.6% (36/107) of cases, respectively. The overall survival (OS) of 77.3% for patients with a normal RB pathway was significantly higher than the OS of 50.0% for patients with an altered RB pathway (by Kaplan-Meier analysis, P = 0.0021). The OS of 66.2% for patients with a normal G2 pathway was significantly higher than the OS of 58.3% for patients with an altered G2 pathway (P = 0.0416). However, the status of the p53 pathway was not related to OS. By univariate and multivariate analyses, advanced stage, high histological grade, altered RB pathway, and altered G2 pathway were significant predictors of poor OS. However, there was no significant relationship between pathway status and chemotherapy response. The status of the RB pathway and of the G2 pathway were independent prognostic factors of EOC.
Insights
Alterations in the RB pathway and G2 pathway are linked to poorer survival in epithelial ovarian cancer (EOC) patients. These pathway statuses are independent prognostic factors for EOC, but not related to chemotherapy response.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cell cycle checkpoints, including the G1-S and G2-M phases, are crucial for preventing uncontrolled cell proliferation.
- Dysregulation of key regulatory pathways like the RB and p53 pathways is implicated in various human cancers, including epithelial ovarian cancer (EOC).
- Understanding the prognostic significance of these cell cycle pathway alterations in EOC is essential for improving patient outcomes.
Purpose of the Study:
- To investigate the status of the RB pathway, p53 pathway, and G2 pathway in epithelial ovarian cancer (EOC) patients.
- To evaluate the association between the status of these cell cycle pathways and patient prognosis, specifically overall survival (OS).
- To determine if pathway status correlates with response to chemotherapy in EOC.
Main Methods:
- Immunohistochemistry was employed to analyze the status of the RB, p53, and G2 pathways in 107 epithelial ovarian cancer (EOC) patient samples.
- Kaplan-Meier analysis and univariate/multivariate analyses were conducted to assess the relationship between pathway status and overall survival.
- Chemotherapy response data was analyzed in conjunction with pathway status.
Main Results:
- Altered RB, p53, and G2 pathways were observed in 50.5%, 51.4%, and 33.6% of EOC cases, respectively.
- Patients with a normal RB pathway exhibited significantly higher overall survival (77.3%) compared to those with an altered RB pathway (50.0%; P = 0.0021).
- A normal G2 pathway was associated with significantly better OS (66.2%) than an altered G2 pathway (58.3%; P = 0.0416), while p53 pathway status showed no OS correlation. Advanced stage, high histological grade, and altered RB/G2 pathways predicted poor OS.
Conclusions:
- The status of the RB pathway and the G2 pathway are independent prognostic factors for overall survival in epithelial ovarian cancer (EOC).
- Altered RB and G2 pathways are significant predictors of poor prognosis in EOC patients.
- Pathway status did not demonstrate a significant relationship with chemotherapy response in this cohort.
Related Concept Videos
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System

